“Cutaneous Drug Reaction Due to Bortezomib Characterized by Erythematous Reticular Plaques in a Patient With Multiple Myeloma”, Dermatol Pract Concept, vol. 14, no. 4, p. e2024243, Oct. 2024, doi: 10.5826/dpc.1404a243.